Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
County Executive Maoming (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Product Specialist Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 30, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jul 29, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
区域市场组经理 Xian (Shanxi Province) China International Innovative Medicines Marketing Jul 28, 2024
MR Wuhu (Anhui Province) China International Innovative Medicines Sales Jul 26, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Jul 23, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 15
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia